Sana biotechnology inc.

Major-Pharmaceuticals

SANA


188 East Blaine Street
Seattle , WA 98102

Executive/
Director

Price

  • Last Close
  • $ 1.7
    $ +0.04 2.72 %
    Jan 3, 2025
  • 52-Week High/Low
  • $11.27 - $2.8
  • YTD
  • 3.7%

  • Trading Volume
  • 48,915
  • Market Cap Full
  • $ 335.1M
  • Shares Outstanding
  • 197.1M
    Oct 31, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - - - -46.7% -17.2% 144.6% 3.7%
Q2 - - - - - -41.3% -22.2% 82.3% -46.7% -
Q3 - - - - - 14.6% -6.7% -35.1% 0.3% -
Q4 - - - - - -31.2% -34.2% 14% -43.2% -
J F M A M J J A S O N D
2025 3.7% - - - - - - - - - - -
2024 34.6% 82.9% -0.6% -23.9% -1.5% -28% 12.7% 0.3% - - - -41%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%0%-74%3%-60%4%

Earnings

2020 2021 2022 2023
Q1 - -1.52 -0.17 -0.43
Q2 - 0.09 -0.39 -0.59
Q3 - -0.46 -0.45 0.00
Q4 - -0.25 -0.42 -
A -21.9 -2.1 -1.4 -1.02

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 189.5 191.4
Jun 187.7 189.7 191.5
Sep 187.9 190.2 196.9
Dec 188.8 190.7 197.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 68.3 357 286 14.1 -
Equity multiplier 0.2 0.4 -0.2 0.1 -